Kyntra Bio (KYNB) Net Equity Issued and Repurchased (2014 - 2024)
Kyntra Bio's Net Equity Issued and Repurchased was $23,000 in Q4 2024.
Powered by 
Analysis
Kyntra Bio (KYNB) Net Equity Issued and Repurchased (2014 - 2024) Analysis & Trends
For FY2024, Net Equity Issued and Repurchased at Kyntra Bio came in at $139,000, down 99.7% from FY2023.
- Net Equity Issued and Repurchased shows a five-year compound annual growth rate of -63.3% (FY2019 to FY2024).
- In earlier years, Net Equity Issued and Repurchased was $48.41 million in FY2023, $4.18 million in FY2022 (-67.1%), $12.7 million in FY2021 (-66.4%) and $37.83 million in FY2020 (+82.1%).
- The Q4 2024 figure marks the lowest quarterly Net Equity Issued and Repurchased since Q2 2017.
- The best year-over-year quarter for Net Equity Issued and Repurchased over five years was Q2 2023 (growth of 580.2%); the worst was Q2 2024 (a decline of 99.3%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,141.09 Bn | 1,109.67 Bn | 19.71 Bn | -1.60 Bn |
| 2 | Johnson & Johnson | 635.15 Bn | 555.01 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 501.95 Bn | 475.07 Bn | 12.70 Bn | -9.00 Mn |
| 4 | Merck | 356.40 Bn | 310.78 Bn | 12.21 Bn | -714.00 Mn |
| 5 | Novartis Ag | 300.55 Bn | 264.54 Bn | 11.24 Bn | -1.20 Bn |
| 6 | Astrazeneca | 263.27 Bn | 236.95 Bn | 12.86 Bn | 6.00 Mn |
| 7 | Amgen | 237.82 Bn | 193.22 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 194.11 Bn | 168.30 Bn | 6.22 Bn | -346.00 Mn |
| 9 | Pfizer | 170.27 Bn | 116.91 Bn | 10.94 Bn | - |
| 10 | Kyntra Bio | 20.16 Mn | -387.78 Mn | 1.47 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 23,000.00 |
| Jun 30, 2024 | 116,000.00 |
| Dec 31, 2023 | 45,000.00 |
| Jun 30, 2023 | 20.44 Mn |
| Mar 31, 2023 | 31.66 Mn |
| Dec 31, 2022 | 1.20 Mn |
| Sep 30, 2022 | 210,000.00 |
| Jun 30, 2022 | 2.60 Mn |
| Mar 31, 2022 | 183,000.00 |
| Dec 31, 2021 | 838,000.00 |
| Sep 30, 2021 | 107,000.00 |
| Jun 30, 2021 | 5.68 Mn |
| Mar 31, 2021 | 6.08 Mn |
| Dec 31, 2020 | 11.58 Mn |
| Sep 30, 2020 | 9.74 Mn |
| Jun 30, 2020 | 9.51 Mn |
| Mar 31, 2020 | 7.00 Mn |
| Dec 31, 2019 | 5.07 Mn |
| Sep 30, 2019 | 2.37 Mn |
| Jun 30, 2019 | 7.77 Mn |
API Access
Kyntra Bio Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=KYNB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "KYNB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=KYNB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();